Genes2Me Blog – CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems

Genes2Me Blog – CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems

Real Time PCR Molecular Diagnostics NGS Cancer Screening Sequencing COVID-19 Rapid Antigen Antibody Made in India Manufacturer Clinical/Whole Exome

Skip to content
Menu
  • Home
  • Visit Genes2Me

Author: Genes2Me

Established in 2016, Genes2Me is a leading molecular diagnostics company committed to transforming healthcare through innovative, high-quality in vitro diagnostic (IVD) solutions. Built on a strong foundation of scientific excellence and precision engineering, Genes2Me develops and manufactures advanced diagnostic technologies that enable accurate, reliable, and timely clinical decision-making across diverse healthcare settings worldwide. With a comprehensive and rapidly expanding portfolio, Genes2Me offers cutting-edge solutions across molecular diagnostics, including Next Generation Sequencing (NGS) clinical assays, point-of-care (POC) testing platforms, RT-PCR kits and instruments, as well as nucleic acid extraction kits and automation systems. Designed to meet the evolving needs of modern laboratories and clinicians, our products combine performance, scalability, and operational efficiency. A vast majority of Genes2Me products are CE-IVD marked, reflecting our commitment to global quality benchmarks, regulatory compliance, and uncompromising product standards. At the heart of our innovation are proprietary platforms such as OnePCR and Rapi-Q, developed to deliver rapid, multiplex, and highly sensitive molecular detection with streamlined workflows and minimal turnaround time. OnePCR integrates automated nucleic acid extraction and RT-PCR into a single, seamless workflow, enabling the detection of up to 20 targets from a single sample with exceptional precision and efficiency. The Rapi-Q series is engineered for fast, sensitive, and multiplex testing with a larger throughput, empowering healthcare providers with timely diagnostic insights that support improved patient outcomes. In genomics, Genes2Me offers one of the industry’s most comprehensive NGS clinical assay portfolios, spanning oncology, liquid biopsy, whole exome sequencing, NIPT and pharmacogenomics. Complementing this portfolio is EZY AutoPrep, our advanced automated library preparation workstation designed to optimize NGS library preparation through enhanced accuracy, reproducibility, and scalability. Our genomics ecosystem is further strengthened by CliSeq Interpreter, a cloud-based bioinformatics platform that enables accurate, flexible, and intuitive interpretation of complex genomic data, helping laboratories generate high-confidence insights with efficiency and ease. Driven by innovation, quality, and a global vision, Genes2Me continues to redefine the future of molecular diagnostics—delivering integrated solutions that advance precision medicine and improve lives worldwide.
Culture Free Sepsis AMR Detection Solution
DiagnosticsPosted onApril 17, 2026May 28, 2026

From Direct Blood to Results in ~2 Hours: A Comprehensive RT-PCR Approach to Culture-free Sepsis and AMR Detection

Sepsis and AMR is one of the most urgent and complex challenges in modern medicine. Despite advances in critical care and infectious disease management, it…

Read More
Diagnostic Ecosystem for TB Control
ManufacturingPosted onApril 2, 2026May 28, 2026

Closing the Diagnostic Gap in Tuberculosis: Why Molecular Diagnostics Matters More Than Ever

On World TB Day, conversations often focus on awareness. However, one of the most critical challenges in tuberculosis (TB) control is delayed and inadequate diagnosis.…

Read More
One-RT-PCR Testing Solution
DiagnosticsPosted onJune 13, 2025May 28, 2026

STI Detection: Ensuring Early Diagnosis for Better Health Outcomes

Sexually transmitted infections (STIs) are a significant global health concern, affecting millions of people each year. According to the World Health Organization (WHO), more than…

Read More
Fully Automated Detection System
DiagnosticsPosted onNovember 28, 2024May 28, 2026

Introducing OnePCR by G2M: A Fully Automated Detection System with Seamless Sample-to-Result Efficiency

G2M is excited to introduce OnePCR, a fully automated detection system that transforms point-of-care testing. With its innovative design, OnePCR offers a simplified sample-to-result process…

Read More
POCT Testing Solutions
COVID-19 Testing KitPosted onAugust 2, 2024May 28, 2026

Point-of-Care Testing – Revolutionizing Clinical Diagnostics and Enhancing Patient Care

Point-of-care testing (POCT) has emerged as a game-changer in the realm of clinical diagnostics, offering healthcare professionals the ability to obtain rapid and reliable diagnostic…

Read More
NIPT Testing Solutions
DiagnosticsPosted onMay 4, 2024May 27, 2026

Non-Invasive Prenatal Testing (NIPT) and Its Benefits in Prenatal Care

From the moment those two pink lines appear on the pregnancy test, expectant parents embark on a journey of anticipation, dreams, hopes, and a myriad…

Read More
EZY-AutoPrep NGS Library Preparation Workstation
ManufacturingPosted onApril 9, 2024May 27, 2026

Revolutionizing Library Preparation through EZY AutoPrep Workstation

In the realm of Next-Generation Sequencing (NGS), library preparation is a critical step that lays the foundation for accurate and reliable sequencing results. Traditionally, library…

Read More
Cancer Diagnosis RT-PCR Panels
DiagnosticsPosted onApril 2, 2024May 26, 2026

Role of RT-PCR in Oncology Detection

Introduction: In the realm of oncology, the quest for early detection methods has been relentless, with researchers continually seeking innovative approaches to combat cancer. Among…

Read More
Revolutionizing Cancer Diagnosis and Treatment
DiagnosticsPosted onMarch 14, 2024May 26, 2026

Revolutionizing Cancer Diagnosis with G2M’s Liquid Biopsy NGS Clinical Panels

In the realm of cancer diagnosis and treatment, the advent of liquid biopsy has sparked a transformative shift. Liquid biopsy, a term encompassing the collection…

Read More
CE-IVD Approved Real Time PCR Kits
COVID-19 RT PCR TestPosted onAugust 30, 2023May 26, 2026

The Significance of IVD RT-PCR Kits in Disease Detection: A Game Changer in Modern Healthcare

In today’s fast-paced world, diagnosing and detecting diseases swiftly and accurately has become pivotal to the diagnostic and healthcare industry. The remarkable advancements in molecular…

Read More

Posts navigation

Previous Page Page 1 Page 2 Page 3 … Page 6 Next Page

Please enable JavaScript in your browser to complete this form.
Name *
Loading

Recent Posts

  • From Reads to Reporting: Solving the NGS Bottleneck with CliSeq Interpreter
  • Beyond Fever: Why Precision Molecular Diagnostics Are Redefining the Fight Against Vector-Borne Diseases
  • One Test. Every Biomarker. Every Solid Tumor PanCan CGP Assay
  • Transforming TB Diagnostics with NGS: Enabling Rapid Detection and Drug-Resistant TB Management with Precision Genomics
  • OncoCheck: Advancing Precision Oncology Through Genomic Insights

Categories

  • Antibody Test
  • Awareness Month
  • BRCA Gene Testing
  • COVID Antibody Test
  • COVID-19 RT PCR Test
  • COVID-19 Testing Kit
  • CYSTIC FIBROSIS
  • Diagnostics
  • Dignostic Solution
  • DNA RNA Solutions
  • Exome Sequencing
  • Extraction Solution
  • Genes2Health
  • Genetic Testing
  • Hepatitis
  • Manufacturing
  • Microarray
  • Mother and Child Care
  • Newborn Screening
  • Next Generation Sequencing
  • NGS Assays
  • NIPT
  • Oncology
  • PCR
  • Personalized Genomics
  • Point of Care Solution
  • Real Time PCR Solutions
  • RT-PCR IVD Solutions
  • RT-PCR Kit
  • TB Diagnostics NGS
  • Whole Exome
© Copyright 2020 – Genes2Me
Allium Theme by TemplateLens ⋅ Powered by WordPress